Cargando…

A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors

Pancreatic neuroendocrine tumors (PanNET) are rare cancers that generally have a poor prognosis. Accurate diagnosis and proper treatment of these tumors requires a better understanding of the molecular mechanisms underlying the development of PanNET. It has been shown that the mTOR inhibitor everoli...

Descripción completa

Detalles Bibliográficos
Autores principales: Takikawa, Masahiro, Ohki, Rieko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480075/
https://www.ncbi.nlm.nih.gov/pubmed/28295876
http://dx.doi.org/10.1111/cas.13235